China Resources Pharma's subsidiary China Resources Jiangzhong earned 906 million RMB last year, an increase of 15%
China Resources Pharma (03320.HK) announced that its subsidiary China Resources Jiangzhong (600750.SH) achieved a total operating revenue of 4.22 billion RMB for the fiscal year 2025, a year-on-year decrease of 4.9%. The net profit attributable to shareholders was 906 million RMB, an increase of 15%, with earnings per share of 1.43 RMB
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments